Published in J Urol on February 01, 1999
Novel approaches in the therapy of metastatic renal cell carcinoma. World J Urol (2005) 2.05
PD-L1 expression in nonclear-cell renal cell carcinoma. Ann Oncol (2014) 1.58
Molecular aspects of renal cell carcinoma: a review. Am J Cancer Res (2010) 1.25
Urinary biomarkers for the early diagnosis of kidney cancer. Mayo Clin Proc (2010) 1.24
A clinical phase I/II trial with the monoclonal antibody cG250 (RENCAREX®) and interferon-alpha-2a in metastatic renal cell carcinoma patients. World J Urol (2010) 1.08
Carbonic anhydrase IX expression in renal neoplasms: correlation with tumor type and grade. Am J Clin Pathol (2010) 0.96
Characterization of a new renal cell carcinoma bone metastasis mouse model. Clin Exp Metastasis (2010) 0.94
Genitourinary malignancy presenting as an ocular metastasis: A case report and review of the literature. Can Urol Assoc J (2012) 0.94
Evaluation of changes in the tumor microenvironment after sorafenib therapy by sequential histology and 18F-fluoromisonidazole hypoxia imaging in renal cell carcinoma. Int J Oncol (2012) 0.93
The specificity of urinary aquaporin 1 and perilipin 2 to screen for renal cell carcinoma. J Urol (2012) 0.91
High CXC chemokine receptor 4 expression is an adverse prognostic factor in patients with clear-cell renal cell carcinoma. Br J Cancer (2014) 0.85
Immunotherapy in metastatic renal cell carcinoma. World J Urol (2005) 0.84
The Place of FDG PET/CT in Renal Cell Carcinoma: Value and Limitations. Front Oncol (2016) 0.83
Tumor type M2 pyruvate kinase expression in metastatic renal cell carcinoma. Urol Res (2003) 0.83
A bone-seeking clone exhibits different biological properties from the ACHN parental human renal cell carcinoma in vivo and in vitro. Oncol Rep (2011) 0.81
Expression of drug targets in primary and matched metastatic renal cell carcinoma tumors. BMC Clin Pathol (2013) 0.81
Downregulation of Bcl-2 sensitises interferon-resistant renal cancer cells to Fas. Br J Cancer (2004) 0.80
Genetic deficiency of complement isoforms C4A or C4B predicts improved survival of metastatic renal cell carcinoma. J Urol (2009) 0.80
Predictive models for the practical management of renal cell carcinoma. Nat Rev Urol (2012) 0.79
Initial experience with arterial spin-labeling MR imaging to assess histology of renal masses. Quant Imaging Med Surg (2013) 0.78
Covalent crosslinking of tumor antigens stimulates an antitumor immune response. Vaccine (2010) 0.78
Prognostic and Predictive Values of Subcellular Localisation of RET in Renal Clear-Cell Carcinoma. Dis Markers (2016) 0.75
Two cases of renal cell cancer during immunobiologic therapy for psoriasis. An Bras Dermatol (2014) 0.75
Low level of PDZ domain containing 1 (PDZK1) predicts poor clinical outcome in patients with clear cell renal cell carcinoma. EBioMedicine (2016) 0.75
Renal Cell Carcinoma: A Study through NMR-Based Metabolomics Combined with Transcriptomics. Diseases (2016) 0.75